Irreversible inactivation of rat gastric (H+-K+)-ATPase invivo by omeprazole

https://doi.org/10.1016/0006-291X(85)90573-XGet rights and content

Abstract

Subcutaneous administration of omeprazole, a gastric antisecretory agent belonging to the family of substituted benzimidazoles, brought about a dose-dependent decrease in gastric mucosal (H+-K+)-ATPase activity in the rat. The dose which inhibited 50% of the enzyme activity was 1 mg/kg from dose-response profiles obtained 3 h after the drug dosing. Duration profiles of the drug at 10 mg/kg showed that its ATPase-inhibitory effect reached the maximum in 2 h with 80% reduction of the enzyme activity. The gastric mucosal level of the ATPase activity remained to be maximally inhibited for 12 h and returned to a normal level with a half time of about 20 h. The return of the enzyme activity, however, was blocked by treatment with cycloheximide, an inhibitor of protein synthesis. These observations indicate that omeprazole irreversibly inactivates gastric (H+-K+)-ATPase invivo.

References (16)

  • A.L. Ganser et al.

    Biochem. Biophys. Acta

    (1973)
  • G. Sachs et al.

    J. Biol. Chem

    (1976)
  • W.B. Im et al.

    Biochim. Biophys. Acta

    (1984)
  • H.H. Chang et al.

    Biochim. Biophys. Acta

    (1977)
  • J.G. Forte et al.

    Biochim. Biophys. Acta

    (1981)
  • G. Saccomani et al.

    J. Biol. Chem

    (1981)
  • B. Wallmark et al.

    Biochim. Biophys. Acta

    (1983)
  • W. Londong et al.

    Gastroenterol

    (1983)
There are more references available in the full text version of this article.

Cited by (84)

  • Characterization of the inhibitory activity of tenatoprazole on the gastric H<sup>+</sup>,K<sup>+</sup>-ATPase in vitro and in vivo

    2006, Biochemical Pharmacology
    Citation Excerpt :

    Thermolysin digestion of TM5/6 labeled by tenatoprazole shows that tenatoprazole labeled both Cys813 and Cys822, as previously found for pantoprazole labeling [10]. No reversal of the inhibited pump by PPIs is seen even after overnight incubation of the inhibited enzyme in vitro [27–29]; hence, the disulfide bonds are stable in the absence of disulfide reducing agents. If synthesis of new pump protein is the only means of generation of active enzyme, in vivo, covalent inhibition of the enzyme would be reversed only by de novo pump synthesis.

  • Molecular and cellular targets in therapy of acid-related diseases

    2005, Therapy of Digestive Disorders, Second Edition
View all citing articles on Scopus
View full text